Kyverna Therapeutics rallies $85m Series B
Kyverna Therapeutics, a cell therapy company, has secured $85 million in Series B financing.
Kyverna Therapeutics, a cell therapy company, has secured $85 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination